SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-24-066162
Filing Date
2024-03-12
Accepted
2024-03-12 21:30:31
Documents
3
Group Members
ATAI LIFE SCIENCES AG

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d757113dsc13da.htm SC 13D/A 64036
2 EX-99.14 d757113dex9914.htm EX-99.14 31697
3 EX-99.15 d757113dex9915.htm EX-99.15 149938
  Complete submission text file 0001193125-24-066162.txt   247488
Mailing Address 6420 ABRAMS SAINT LAURENT A8 H4S 1Y2
Business Address 6420 ABRAMS SAINT LAURENT A8 H4S 1Y2 514-331-7440
IntelGenx Technologies Corp. (Subject) CIK: 0001098880 (see all company filings)

IRS No.: 870638336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-82768 | Film No.: 24744388
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 524 BROADWAY NEW YORK NY 10013
Business Address WALLSTRASSE 16 BERLIN 2M 10179 (617)-699-5876
ATAI Life Sciences N.V. (Filed by) CIK: 0001840904 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)